SCHEMBL5870313

SCHEMBL5870313

O=C(O)C(NC1(C(=O)O)CCCCC1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.40
AKR1C1 Q04828 1/20 0.40
FABP4 P15090 5/20 0.39
FABP5 Q01469 5/20 0.39
GAA P10253 1/20 0.38
HDAC4 P56524 1/20 0.38
CTSK P43235 1/20 0.38
KMT2A Q03164 1/20 0.37
USP2 O75604 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CYP2D6 P10635 1/20 0.37
SRC P12931 1/20 0.37
CYP1A2 P05177 1/20 0.37
FPR2 P25090 1/20 0.37
FAAH O00519 1/20 0.37
CTSL P07711 1/20 0.37
TRPV1 Q8NER1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8257823 1.00 ALDH1A1 (0.40) ALDH1A1AKR1C1FABP4FABP5GAA
SCHEMBL4368196 0.77 CTSK (0.42) ALDH1A1AKR1C1FABP4FABP5CTSK
SCHEMBL3259889 0.75 LMNA (0.51) ALDH1A1GAAKMT2AUSP2
SCHEMBL3259891 0.75 LMNA (0.51) ALDH1A1GAAKMT2AUSP2
SCHEMBL13624184 0.75 CTSL (0.42) ALDH1A1AKR1C1FABP4FABP5CTSK
SCHEMBL28370198 0.74 LMNA (0.42) ALDH1A1HDAC4KMT2ACYP2D6SRC
SCHEMBL4079580 0.72 LMNA (0.45) ALDH1A1FABP4FABP5HTTSMN1; SMN2
SCHEMBL1838386 0.72 ALDH1A1 (0.47) ALDH1A1FABP4FABP5FAAH
SCHEMBL1839565 0.72 ALDH1A1 (0.47) ALDH1A1FABP4FABP5FAAH
SCHEMBL1838384 0.72 ALDH1A1 (0.47) ALDH1A1FABP4FABP5FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7045532-B2 ACE-2 modulating compounds and methods of use thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2006-05-16 US disclosed
US-6632830-B1 Blood pressure related disease or disorder, cell proliferation disorder, kidney disorder, kinetensin associated disorder, inflammation associated disorder, or an allergic disorder MILLENNIUM PHARMACEUTICALS, INC. 2003-10-14 US disclosed